Editorial Expression of Concern: Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
British Journal of Cancer, Published online: 05 November 2026; doi:10.1038/s41416-026-03651-3 Editorial Expression of Concern: Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
A. Tannapfel, K. Engeland, L. Weinans, A. Katalinic, J. Hauss, J. Mössner et al. Editorial Expression of Concern: Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver. // British Journal of Cancer. – 2026. – DOI: 10.1038/s41416-026-03651-3. – URL: https://www.nature.com/articles/s41416-026-03651-3
A. Tannapfel, K. Engeland, L. Weinans, A. Katalinic, J. Hauss, J. Mössner, & Ch Wittekind (2026). Editorial Expression of Concern: Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver. British Journal of Cancer. https://doi.org/10.1038/s41416-026-03651-3
A. Tannapfel, et al. “Editorial Expression of Concern: Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver.” British Journal of Cancer, 2026. doi:10.1038/s41416-026-03651-3.
@article{Tannapfel2026,
title = {Editorial Expression of Concern: Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver},
author = {Tannapfel, A. and Engeland, K. and Weinans, L. and Katalinic, A. and Hauss, J. and Mössner, J. and Wittekind, Ch},
journal = {British Journal of Cancer},
year = {2026},
doi = {10.1038/s41416-026-03651-3},
url = {https://www.nature.com/articles/s41416-026-03651-3}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment